Silano, Julia A.
Treloar, Carla
Leadbeatter, Kyle
Davidson, Sandy
Doidge, Justine
Article History
Received: 18 December 2021
Accepted: 21 March 2022
First Online: 21 April 2022
Declarations
:
: Not applicable.
: Not applicable.
: All of the authors have reported no potential conflict of interest. Carla Treloar has received speaker feesĀ from AbbVie and Gilead and research funding from Merck. Hepatitis NSW has received some fundingĀ from AbbVie and MSD for elements of the LHCF project.